Using PI3Kγ selective inhibitor attenuated the immunosuppressive effect of PLG‐CA4 treatment by decreasing the number of M2‐like TAMs and potential enhancement of CTLs, which significantly prevents tumor development and prolongs the survival. The gene discussed is CA4; the disease is neoplasm.